Table 1.
N | 39 |
Age mean (range) | 72.5 (57–85) |
Gender | |
Male | 34 (87%) |
Female | 5 (13%) |
IPF diagnosis | |
Definite | 19 (49%) |
Probable | 20 (51%) |
Smoking status | |
Ex-smoker | 29 (74%) |
Never-smoker | 10 (26%) |
Antifibrotic therapy | |
Yes | 8 (20%) |
No | 31 (80%) |
FVC; mean (IQR;SD) | 70.9% (63.1–80.7;14.1) |
TLCO; mean (IQR;SD) | 49.5%(35.0–57.8;14.9) |
CPI; mean (IQR;SD) | 47.8% (41.2–57.6;12.3) |
Median period of follow-up in months, mean (IQR;SD) | 29.6 (9.1–30.2;14.3) |
No (%) alive at follow-up | 13 (33) |
Pulmonary function test refers to % predicted for age, gender and height. unless stated, % in parentheses refer to % of cohort.
CPI, Composite Physiologic Index; FVC, forced vital capacity; IPF, idiopathic pulmonary fibrosis; TLCO, transfer factor for carbon monoxide.